Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Nolla Health Announces Nation's First AI to Issue Initial Prescriptions


      News provided by

      Nolla Health

      Oct 05, 2026, 12:00 ET

      Share this article

      Share this article


      Nolla Derm helps the 90% of Utah residents who never reach a dermatologist receive AI-issued initial acne treatment within minutes, starting at $4.99 a month

      SALT LAKE CITY, Oct. 5, 2026 /PRNewswire/ -- Nolla Health, the company pioneering AI-powered personal healthcare, today announced that it has become the first organization in the country to receive regulatory approval for AI to issue initial prescriptions. Starting in Utah through its Nolla Derm app, Nolla's system will prescribe acne prescriptions to help patients better access dermatology care without a waitlist, office visit, or unaffordable bill. The system is available today, and Utah residents 18 years and older can sign up here.

      "AI will matter most in healthcare when it helps people get care they otherwise would not receive," said Luis Wenus, co-founder and CEO of Nolla Health. "Growing up with a doctor in the family, I saw how powerful it was to have trusted medical help within reach, and millions of people do not have that today. With Nolla Derm, we are showing how AI can responsibly expand that access and help someone get personalized treatment in minutes instead of long waits or going without care altogether. That's the future Nolla is building towards: AI helping high-quality healthcare reach far more people."

      Over 80 percent of U.S. counties are considered healthcare deserts, impacting more than 120 million people, or about one in three Americans. In Utah, an estimated 100,000 people live with active acne at any given time, yet only 10 percent ever see a dermatologist. The average wait time in Utah is 61 days, nearly double the national median, with 11 counties having no dermatologists at all. People who land an appointment can pay up to $300 per visit. For patients with untreated acne, the condition can progress to permanent scarring while they wait, driving treatment costs even further.

      Nolla Derm and the Utah pilot program were built to close this access gap. Following months of collaboration with the Utah Office of Artificial Intelligence, Nolla Health secured regulatory approval for the nation's first AI system authorized to issue initial prescriptions under physician oversight. Nolla Health also met and worked directly with the Utah Medical Board ahead of launch to ensure the Board's feedback was reflected in the final program.

      Unlike telehealth platforms that use AI only to collect information before handing patients off to clinicians, Nolla's AI system is designed to independently issue initial prescriptions within tightly defined, physician-approved treatment protocols. The pilot and Nolla's AI system represent a new model for delivering routine healthcare safely, quickly, and affordably at scale, particularly for patients who may otherwise never reach a physician or specialist.

      How It Works
      Eligible Utah residents can download the Nolla Derm app and opt into the program for a discounted rate of $4.99 a month, a fraction of the cost of traditional healthcare. After completing an informed consent process, a 10- to 15-minute intake questionnaire, and a face scan, patients receive a personalized treatment plan and prescription directly through the app in minutes. If the AI cannot confidently select a treatment, the patient is directed to a licensed physician rather than receiving an uncertain recommendation. 

      Physician oversight is built into every stage of the program:

      • Stage one (first 100 patients): A licensed physician reviews and approves every AI-generated prescription before it is sent to the patient.
      • Stage two (first 500 patients): Prescriptions are issued by the AI autonomously, with a physician conducting a daily retroactive review.
      • Stage three: A physician retroactively reviews a sampling of prescriptions once per week.

      Patients receive their prescription via home delivery or pharmacy pickup. Daily skin scans track progress over time, and treatment plans are updated monthly based on each patient's response to care. Patients can message a licensed physician directly through the app at any time – they are never speaking with AI when they reach out for support.

      "The Nolla Health pilot program represents a significant step forward in leveraging AI to improve healthcare access for Utahns, while maintaining rigorous oversight and safety," said Office of Artificial Intelligence Policy Director Zach Boyd. "Our Office facilitates innovative AI solutions while ensuring that public health and patient safety remain paramount."

      The pilot is designed to complement, not replace, physicians. By handling routine, low-acuity cases, Nolla Derm frees dermatologists to focus on complex, high-risk patients – including those at risk for skin cancer – and closes the access gap without burning out the doctors already stretched thin.

      Built on Safety and Clinical Evidence
      Developed with the Utah Office of Artificial Intelligence, the pilot underwent multiple rounds of external review by practicing physicians, dermatologists, key stakeholders, and members of the Utah government before launch. Nolla Derm's AI has already demonstrated strong clinical performance. Licensed clinicians agree with its treatment recommendations in over 96% of real-world cases, with the remaining cases reflecting minor adjustments such as topical strength modifications, not fundamental disagreements with the prescribed treatment.

      Acne is the right starting point for AI in healthcare. It is a well-understood, low-risk condition with decades of clinical evidence behind it, where AI can deliver real value responsibly. Nolla Derm's system cannot generate open-ended prescriptions or improvise treatments. It can only select between pre-approved treatment pathways using structured clinical data and objective facial scan analysis.

      "People are right to worry about AI in medicine that nobody can control. This program was built to be the opposite," said Dr. Zaid Fadul, Chief Medical Advisor for Nolla Health and part of the physician team overseeing the Utah pilot. "The AI can't improvise. It can only choose from a short list of physician-approved topical treatments. The moment a patient falls outside those limits, it stops and hands them to a doctor. The real test for AI in healthcare isn't how smart it is. It's whether someone other than the company can shut it off. In Utah, the state can, and physicians can - that's the standard every AI in medicine should meet."

      The Nolla Derm app has been downloaded by more than 175,000 people across 44 states. To learn more, you can download the app in the App Store or visit: https://www.nollahealth.com/skincare.

      About Nolla Health:
      Nolla Health is an AI-powered personal healthcare company dedicated to providing clinician access and ongoing care – regardless of income or zip code. Beginning with acne and skin health, Nolla combines proprietary AI with clinician oversight to deliver diagnosis, treatment, prescriptions, and follow-up in one seamless experience. Headquartered in New York, Nolla operates across 44 states. Learn more at https://www.nollahealth.com/.

      SOURCE Nolla Health

      Modal title

      Also from this source

      Nolla Health Expands Medical Advisory Board and Clinical Leadership to Help Shape the Future of AI-Powered Healthcare

      Nolla Health Expands Medical Advisory Board and Clinical Leadership to Help Shape the Future of AI-Powered Healthcare

      Nolla Health, an AI-first healthcare platform focused on transforming the patient and provider experience, today announced that Dr. Zaid Fadul has...

      More Releases From This Source

      Explore

      Cosmetics and Personal Care

      Cosmetics and Personal Care

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      International Medical Approval

      International Medical Approval

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.